Lamivir HBV Tablet

Lamivir HBV is indicated for patients with active HBV infection exhibiting elevated serum aminotransferase levels and evidence of viral replication. The medication is generally well tolerated, with common adverse effects including headache, fatigue, and gastrointestinal disturbances such as nausea and abdominal discomfort. Resistance to lamivudine may develop with prolonged use; therefore, regular monitoring of viral load and liver function tests is recommended during therapy.

Lamivir HBV should be used under medical supervision, especially in patients with pre-existing liver conditions or co-infections such as HIV. Dose adjustments may be necessary in patients with renal impairment. Adherence to prescribed dosing regimens is critical to prevent resistance and achieve optimal therapeutic outcomes in the management of chronic hepatitis B.